Bio Availability or Bio Equivalence study [Design Issues]

posted by jag009  – NJ, 2016-05-10 01:09 (3690 d 06:03 ago) – Posting: # 16285
Views: 9,856

Hi Ohlbe

❝ Do you think an extended release formulation can be bioequivalent to an immediate release fomulation ?


It is possible if he is talking about a ER q.d. vs IR b.i.d (or t.i.d, or q.i.d.) formulation under the same total daily dose where in some cases one might want to demonstrate bioquivalence between the two products. Example, Ultram ER is bioequivalent to Tramadol IR (given as qid)....

John

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
160 visitors (0 registered, 160 guests [including 14 identified bots]).
Forum time: 07:13 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5